JNGLX
Price
$74.87
Change
+$0.31 (+0.42%)
Updated
Oct 9 closing price
Net Assets
4.57B
RYOAX
Price
$61.09
Change
+$0.49 (+0.81%)
Updated
Oct 8 closing price
Net Assets
93.68M
Interact to see
Advertisement

JNGLX vs RYOAX

Header iconJNGLX vs RYOAX Comparison
Open Charts JNGLX vs RYOAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$74.87
Change+$0.31 (+0.42%)
VolumeN/A
Net Assets4.57B
Rydex Biotechnology H
Price$61.09
Change+$0.49 (+0.81%)
VolumeN/A
Net Assets93.68M
JNGLX vs RYOAX Comparison Chart in %
View a ticker or compare two or three
VS
JNGLX vs. RYOAX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and RYOAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.57B vs. RYOAX (93.7M). JNGLX pays higher dividends than RYOAX: JNGLX (0.33) vs RYOAX (0.00). JNGLX was incepted earlier than RYOAX: JNGLX (27 years) vs RYOAX (28 years). RYOAX (1.69) is less costly to investors than JNGLX (0.80). RYOAX is a more actively managed with annual turnover of: 79.00 vs. JNGLX (35.00). JNGLX (2500) and RYOAX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : -6.06 vs. RYOAX (-6.38). JNGLX return over 5 years is better than : 8.53 vs. RYOAX (-27.83).
JNGLXRYOAXJNGLX / RYOAX
Total Expense Ratio0.801.6449%
Annual Report Gross Expense Ratio0.801.6947%
Fund Existence27 years28 years-
Gain YTD9.82517.28357%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.57B93.7M4,880%
Annual Yield % from dividends0.330.00-
Returns for 1 year-6.06-6.3895%
Returns for 3 years26.3311.93221%
Returns for 5 years8.53-27.83-31%
Returns for 10 years41.61-19.61-212%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACAAX45.05N/A
N/A
Alger Capital Appreciation A
ACIHX71.15N/A
N/A
American Century Growth G
DHAMX16.90N/A
N/A
Centre American Select Equity Advisor
AHSZX21.09N/A
N/A
Alger Health Sciences Z
PGLEX20.21-0.17
-0.83%
Putnam Focused International Equity R6